|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1300 AUD | +4.00% |
|
-3.70% | -13.33% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 66.73 | - |
| Change | - | - | 343.99% | -44.65% | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 51.23 | 45.23 |
| Change | - | - | 241.42% | -44.75% | -11.71% |
| P/E | -2.64x | -3.27x | -14.3x | -5.65x | -21.7x |
| PBR | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.3x |
| Capitalization / Revenue | - | - | - | - | 6.67x |
| EV / Revenue | - | - | - | - | 4.52x |
| EV / EBITDA | - | - | -11.2x | -4.45x | -12.9x |
| EV / EBIT | - | - | -11.1x | -4.42x | -12.6x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.006 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 10 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -3.5 |
| EBIT 1 | - | - | -8.389 | -11.6 | -3.6 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -3.6 |
| Net Debt 1 | - | - | -27.85 | -15.5 | -21.5 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1300 | 0.1300 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.43x | - | -4.23x | - | 44.98M | |
| 20.76x | 6.35x | 13.89x | 1.53% | 55.23B | |
| 31.7x | 7.83x | 24.1x | 0.05% | 53.75B | |
| -18.35x | 4.4x | -7.71x | -.--% | 23.48B | |
| -39.73x | 12.6x | -37.13x | -.--% | 22B | |
| 24.86x | 4.85x | 12.85x | -.--% | 19.78B | |
| 24.09x | 4.69x | 15.26x | -.--% | 17.44B | |
| -736.67x | 34.86x | -3924.15x | -.--% | 14.66B | |
| 17.61x | 5.1x | 11.9x | -.--% | 14.07B | |
| 39.36x | 15.8x | 40.68x | 0.09% | 13.02B | |
| Average | -64.18x | 10.72x | -385.45x | 0.19% | 23.35B | |
| Weighted average by Cap. | -32.47x | 9.08x | -236.60x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
